Jose Fernandez-Correa

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Impact of Working From Home on the Psychological Well-Being of 365 European Patients With Rheumatic Diseases During COVID-19 Pandemic. Results of the REUMAVID Study.

Impact of Working From Home on the Psychological Well-Being of 365 European Patients With Rheumatic Diseases During COVID-19 Pandemic. Results of the REUMAVID Study.

Journal: Musculoskeletal care

Published: March 13, 2025

Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS).

Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS).

Journal: Musculoskeletal care

Published: October 22, 2024

Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS).

Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS).

Journal: Reumatologia clinica

Published: June 28, 2024

Females With Axial Spondyloarthritis Have Longer Diagnostic Delay and Higher Burden of the Disease. Results From the International Map of Axial Spondyloarthritis (IMAS).

Females With Axial Spondyloarthritis Have Longer Diagnostic Delay and Higher Burden of the Disease. Results From the International Map of Axial Spondyloarthritis (IMAS).

Journal: International journal of rheumatic diseases

Published: June 27, 2024

Patient journey, disease burden, and functional disability in patients with axial spondyloarthritis in South Africa: results of International Map of Axial Spondyloarthritis (IMAS).

Patient journey, disease burden, and functional disability in patients with axial spondyloarthritis in South Africa: results of International Map of Axial Spondyloarthritis (IMAS).

Journal: Clinical rheumatology

Published: April 11, 2024

Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS).

Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS).

Journal: Rheumatology and therapy

Published: February 15, 2024

Factors Associated with Poor Mental Health in Patients with Axial Spondyloarthritis: Results from the International Map of Axial Spondyloarthritis (IMAS).

Factors Associated with Poor Mental Health in Patients with Axial Spondyloarthritis: Results from the International Map of Axial Spondyloarthritis (IMAS).

Journal: RMD open

Published: February 14, 2024

Diagnostic delay in patients from the International Map of Axial Spondyloarthritis: geographic, sociodemographic and disease-related factors.

Diagnostic delay in patients from the International Map of Axial Spondyloarthritis: geographic, sociodemographic and disease-related factors.

Journal: Rheumatology (Oxford, England)

Published: November 30, 2023

Regional differences in clinical phenotype of axial spondyloarthritis: results from the International Map of Axial Spondyloarthritis (IMAS).

Regional differences in clinical phenotype of axial spondyloarthritis: results from the International Map of Axial Spondyloarthritis (IMAS).

Journal: Rheumatology (Oxford, England)

Published: September 04, 2023

International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globe.

International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globe.

Journal: RMD open

Published: July 31, 2023

Fears and hopes of patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic across Europe. Results from the REUMAVID study (phase 1 and phase 2).

Fears and hopes of patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic across Europe. Results from the REUMAVID study (phase 1 and phase 2).

Journal: Musculoskeletal care

Published: February 08, 2023

Patients with Axial Spondyloarthritis are Great Consumers of Healthcare Resources, Especially Young and Women: Results from the Spanish Atlas.

Patients with Axial Spondyloarthritis are Great Consumers of Healthcare Resources, Especially Young and Women: Results from the Spanish Atlas.

Journal: Rheumatology and therapy

Published: September 15, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026